HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 113 filers reported holding HARROW HEALTH INC in Q4 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $273 | -53.6% | 13,087 | -70.5% | 0.00% | – |
Q1 2024 | $588 | -5.8% | 44,398 | -20.5% | 0.00% | – |
Q4 2023 | $624 | +21.2% | 55,815 | +55.6% | 0.00% | – |
Q3 2023 | $515 | +104.4% | 35,864 | +170.8% | 0.00% | – |
Q2 2023 | $252 | -62.6% | 13,244 | -58.3% | 0.00% | – |
Q1 2023 | $673 | +175.8% | 31,774 | +91.7% | 0.00% | – |
Q4 2022 | $244 | -99.4% | 16,573 | +365.5% | 0.00% | – |
Q3 2022 | $43,000 | +138.9% | 3,560 | +44.3% | 0.00% | – |
Q2 2022 | $18,000 | +5.9% | 2,467 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | -59.5% | 2,467 | -50.0% | 0.00% | – |
Q4 2021 | $42,000 | -14.3% | 4,934 | -8.8% | 0.00% | – |
Q3 2021 | $49,000 | +113.0% | 5,412 | +119.8% | 0.00% | – |
Q2 2021 | $23,000 | -92.6% | 2,462 | -95.6% | 0.00% | – |
Q3 2020 | $310,000 | +21.1% | 55,495 | +12.9% | 0.00% | – |
Q2 2020 | $256,000 | +25500.0% | 49,136 | +12898.9% | 0.00% | – |
Q1 2020 | $1,000 | -99.7% | 378 | -99.3% | 0.00% | – |
Q3 2019 | $309,000 | – | 55,047 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,710,000 | $14,119,000 | 2.85% |
Diametric Capital, LP | 288,238 | $1,502,000 | 1.15% |
Birchview Capital, LP | 180,000 | $938,000 | 0.57% |
Sio Capital Management, LLC | 238,623 | $1,243,000 | 0.36% |
CORRADO ADVISORS, LLC | 43,400 | $226,000 | 0.20% |
CADENCE CAPITAL MANAGEMENT LLC | 241,450 | $1,258,000 | 0.18% |
BARD ASSOCIATES INC | 287,250 | $1,495,000 | 0.17% |
PRELUDE CAPITAL MANAGEMENT, LLC | 195,876 | $1,021,000 | 0.06% |
Uniplan Investment Counsel, Inc. | 151,305 | $788,000 | 0.06% |
HighVista Strategies LLC | 10,300 | $54,000 | 0.04% |